|Day Low/High||2.76 / 2.86|
|52 Wk Low/High||0.88 / 3.20|
Investors in Catalyst Pharmaceuticals Inc saw new options begin trading today, for the March 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Investors eyeing a purchase of Catalyst Pharmaceuticals Inc shares, but cautious about paying the going market price of $3.04/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the July put at the $2.50 strike, which has a bid at the time of this writing of 5 cents.
Top-line Results and NDA Re-Submission Expected 2017
Company to Host Quarterly Conference Call at 8:30 am ET Tomorrow
Here's a technical look at how to trade several under-$10 triggering breakout trades.
Catalyst Pharmaceuticals' (CPRX) stock rating was boosted to 'overweight' at Piper Jaffray on Wednesday.